XZXue-Jing Zhang

Xue-Jing Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xue-Jing Zhang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:

  • Ming Yan

    School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China

    37 shared publications
  • Ming Yan

    Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China

    10 shared publications
  • Yong Zou

    Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China

    7 shared publications
  • Yong Zou

    State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, PR China

    7 shared publications
  • Jie Chen

    Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 P. R. China

    6 shared publications
  • Lei Chen

    Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 People's Republic of China

    6 shared publications

Latest Publications

  • Thianthrenium Salt-Mediated Site-Selective Coupling of Arenes with Enynones

    by Shihaozhi Wang, Jia-Hui Shi, Shan Xu, Xue-Jing Zhang, Ming Yan

    Herein, we report a palladium-catalyzed, diazo-free, regioselective carbene coupling reaction of unactivated arenes with furyl carbenes, which are readily generated in situ from enynones, serving as safe and practical surrogates for traditional carbene sources. In this transformation, arenes are first thianthrenated, followed by a cascade reaction of cycloisomerization, migratory insertion, and β-hydride elimination with enynones to afford furyl-substituted alkenylarenes. This highly site-selective olefination features excellent safety, a broad substrate scope, and good tolerance of halogen substituents. Notably, the successful derivatization of drug(like) molecules demonstrates the substantial potential of this method for the late-stage functionalization of arene-based drugs.

  • Structural Modification and Prodrug Design Based on Natural Stilbene Scaffold for the Discovery of Novel PARP-1 Inhibitors with Improved Antitumor Activity

    by Zhiru Zou, Guoqing Lu, Meixiu Xin, Zhibo Du, Zhuo Cheng, Shaoqiang Wu, Xinwei Chen, Guanbing Chen, Yuchen Cai, Xuejing Zhang, et al.

    Poly(ADP-ribose) polymerase-1 (PARP-1) plays a critical role in DNA damage repair and has emerged as a synthetic lethal target for BRCA mutant cancers. Herein, we report the discovery of novel PARP-1 inhibitors based on the natural stilbene scaffold through structural modification and ROS-responsive prodrug optimization. A series of stilbene derivatives with ortho-hydroxybenzamide scaffold were designed and synthesized. Among them, compound 24c demonstrated potent antiproliferative activity against BRCA1-deficient cell lines (SUM149PT, MDA-MB-436, and HCC1937) and the BRCA2-deficient cell line (Capan-1). Mechanistic studies revealed that 24c effectively inhibited intracellular PARP-1 activity, exacerbated DNA double-strand breaks, induced ROS generation, and decreased mitochondrial membrane potential, ultimately leading to cell cycle arrest and apoptosis. To enhance in vivo efficacy, ROS-responsive prodrugs were designed and synthesized, with P-24c demonstrating excellent antitumor activity (TGI = 69.3%) and low toxicity in a SUM149PT xenograft model. This work provides a valuable paradigm for developing novel antitumor agents from privileged natural scaffolds.


  • Skeletal Editing of 4-Substituted Isothiazoles to Pyrazoles Via a Two-Atom N–S to N–N Swap

    by Bao-Qin Huang, Jin-Zhen Xu, Zi-Cheng Huang, Xue-Jing Zhang, Ming Yan

    We report a Tf2O-promoted skeletal editing of 4-substituted isothiazoles to pyrazoles via a two-atom N–S to N–N swap. The reaction proceeds via activation of the isothiazole ring by Tf2O, followed by a nucleophilic addition/Dimroth rearrangement cascade in a one-pot process under mild conditions. A range of 4-substituted isothiazoles bearing various electronic and steric substituents are compatible, affording the corresponding pyrazoles in moderate to good yields. The method is scalable to gram-scale synthesis and allows late-stage modification of drug-derived isothiazole derivatives, demonstrating its utility for scaffold hopping in medicinal chemistry. This work establishes Tf2O activation as a viable platform for skeletal editing of five-membered heteroarenes, providing a mild and modular entry to pyrazoles from isothiazoles.


  • Photochemical Synthesis of DNA-Encoded 3 H -Azepines via Skeletal Editing of Nitroarenes

    by Jia-Ying Xue, Jia-Hui Shi, Yuan Yao, Wei-En Xie, Yong Zou, Ming Yan, Xue-Jing Zhang

    We report a skeletal editing strategy based on DNA-encoded nitroarenes for the direct conversion of benzene cores into valuable 3H-azepine scaffolds. This transformation is efficiently promoted by visible light in the presence of P(Oi-Pr)3, which serves as a reductant to generate reactive nitrene intermediates from the nitro group. Demonstrating broad substrate scope with applicability to pharmaceutical molecules, this protocol offers an efficient and versatile route to DNA-encoded 3H-azepine derivatives. It thus establishes a robust platform for skeletal diversification in DNA-encoded library synthesis.


  • Pd-Catalyzed C–H/C–C Cascade Activation for the Synthesis of γ-Lactams

    by Peng Zhang, Shihaozhi Wang, Shan Xu, Xue-Jing Zhang, Ming Yan

    This work establishes a palladium-catalyzed cascade reaction combining C(sp3)-H functionalization and C-C bond cleavage of cyclopropanes, enabling the direct and efficient construction of biologically relevant dihydro-2H-pyrrol-2-ones (γ-lactams) from readily accessible cyclopropanecarboxamides and diazo compounds. By introducing an α-substituent and directing group, this strategy facilitates the C-H activation of the cyclopropanes and the subsequent carbene migratory insertion, followed by directing group assisted β-carbon elimination enabling selective C-C cleavage. This method offers a concise and efficient approach to accessing γ-lactam-containing architectures of pharmaceutical interest.


  • Site-Selective C–H Annulation Reaction via Thianthrenium Salts of Arenes

    by Bao-Qin Huang, Xin-Xiang Xu, Bing-Hao Wu, Yong Zou, Xue-Jing Zhang, Ming Yan

    This work presents a site-selective C-H annulation strategy for dihydrobenzoisoxazole synthesis using readily accessible thianthrenium salts as aryne precursors. The process involves base-mediated generation of reactive aryne intermediates from thianthrenium salts followed by regioselective [3 + 2] cycloaddition with nitrone 1,3-dipoles, exhibiting excellent functional group tolerance and exceptional regiocontrol. The synthetic utility of this protocol is highlighted by the successful annulation of commercially available drug molecules, providing expedient access to novel scaffolds with potential bioactivity.


  • Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

    by Cheng-Xin Li, Zhi-Ru Zou, Shan Xu, Jia-Hui Shi, Yong Zou, Ming Yan, Xue-Jing Zhang

    A class of Pt(IV)-PROTAC complexes was designed and synthesized with dual aims of inducing DNA strand damage and inhibiting DNA repair. These complexes showed good antiproliferative activity against a range of cancer cell lines. Enhanced intracellular uptake of platinum and PROTAC was observed. Multiple mechanisms of action were identified, including the induction of DNA damage, disruption of DNA repair, and activation of mitochondrial-dependent apoptosis. One of the Pt(IV)-PROTACs, CW-2, showed excellent antitumor activity in a xenograft mouse model. These results suggest that Pt(IV)-PROTAC represents a promising strategy for the development of novel antitumor therapeutics.


  • Solvent-Controlled Rh(III)-Catalyzed Mono- and Dual Functionalization of Quinolyl Aldoximes with Diazo Compounds

    by Peng Zhang, Shan Xu, ShihaoZhi Wang, Xue-Jing Zhang, Ming Yan

    A solvent-controlled Rh(III)-catalyzed mono- and dual-C–H bond activation/carbene migratory insertion with diazo compounds as a single coupling partner was demonstrated. The reaction proceeded under mild conditions, yielding products in good to excellent yields. These results are significant for the development of the domino multiple functionalization of C(sp2)–H bonds via a carbenoid insertion approach.


  • Molecular Editing of Pyrroles to Benzenes/Naphthalenes by N2O Deletion.

    by Wen‐Jie Xiao, Cheng‐Xin Li, Jing‐Yi Lv, Shan Xu, Wen‐Xia Shi, Xiao‐Can Su, Jia‐Ying Xue, Bao‐Qin Huang, Yong Zou, Ming Yan, et al.

    Molecular editing promises to facilitate the rapid diversification of complex molecular architectures by rapidly and conveniently altering core frameworks. This approach has the potential to accelerate both drug discovery and total synthesis. In this study, we present a novel protocol for the molecular editing of pyrroles. Initially, N‐Boc pyrroles and alkynes are converted into N‐bridged compounds through a Diels–Alder reaction. These compounds then undergo deprotection of the Boc group, nitrosylation, and cheletropic N2O extrusion to yield benzene or naphthalene products. By using benzyne as a substrate, this method can be conceptually viewed as a fusion of skeletal editing of the pyrrole ring and site‐selective peripheral editing of the benzene ring. Furthermore, this proof‐of‐concept protocol has demonstrated its potential to transform the (hetero)arene motif from commercially available drugs, offering the possibility of generating new biologically active compounds.


  • Molecular Editing of Pyrroles to Benzenes/Naphthalenes by N2O Deletion.

    by Wen‐Jie Xiao, Cheng‐Xin Li, Jing‐Yi Lv, Shan Xu, Wen‐Xia Shi, Xiao‐Can Su, Jia‐Ying Xue, Bao‐Qin Huang, Yong Zou, Ming Yan, et al.

    Molecular editing promises to facilitate the rapid diversification of complex molecular architectures by rapidly and conveniently altering core frameworks. This approach has the potential to accelerate both drug discovery and total synthesis. In this study, we present a novel protocol for the molecular editing of pyrroles. Initially, N‐Boc pyrroles and alkynes are converted into N‐bridged compounds through a Diels–Alder reaction. These compounds then undergo deprotection of the Boc group, nitrosylation, and cheletropic N2O extrusion to yield benzene or naphthalene products. By using benzyne as a substrate, this method can be conceptually viewed as a fusion of skeletal editing of the pyrrole ring and site‐selective peripheral editing of the benzene ring. Furthermore, this proof‐of‐concept protocol has demonstrated its potential to transform the (hetero)arene motif from commercially available drugs, offering the possibility of generating new biologically active compounds.